Data as of Sep 13, 2026. Both funds on the fields they both publish, from the same sources.
DIA vs XBI: how they differ
DIA and XBI hold 1% of their weight in the same names, and XBI returned more over the year.
SPDR Dow Jones Industrial Average ETF Trust and State Street(R) SPDR(R) S&P(R) Biotech ETF.
What they hold in common
By the books each fund has filed, DIA and XBI hold 1% of their money in the same securities at the same weight.
| Holding | DIA | XBI |
|---|---|---|
| AMGEN INC | 4.36% | 1.09% |
| US DOLLAR | 0.24% | 0.02% |
| Only in DIA | Only in XBI |
|---|---|
| GOLDMAN SACHS GROUP INC 11.61% | MODERNA INC 2.87% |
| CATERPILLAR INC 9.17% | TWIST BIOSCIENCE CORP 1.81% |
| MICROSOFT CORP 5.61% | HALOZYME THERAPEUTICS INC 1.47% |
| UNITEDHEALTH GROUP INC 4.42% | NATERA INC 1.46% |
| TRAVELERS COS INC/THE 4.19% | KYMERA THERAPEUTICS INC 1.45% |
| VISA INC CLASS A SHARES 4.18% | TRAVERE THERAPEUTICS INC 1.40% |
| JPMORGAN CHASE + CO 4.03% | ROIVANT SCIENCES LTD 1.39% |
| ALPHABET INC CL A 3.79% | ORUKA THERAPEUTICS INC 1.38% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 10, 2026.
| DIA SPDR Dow Jones Industrial Average ETF Trust | XBI State Street(R) SPDR(R) S&P(R) Biotech ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | State Street | State Street |
| What it is | Dow Jones Industrial Average | SPDR S&P Biotech |
| Total return, 1 year | +15.6% | +64.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −1.9 pts | +46.5 pts |
| Expense ratio | not published | 0.35% |
| Already in the S&P 500 | 97.1% | 8.5% |
| Holdings | 31 | 154 |
DIA in plain words
DIA is an index equity fund tracking the Dow Jones Industrial Average. Over the year to Sep 11, 2026 it returned +15.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. By its holdings filed for Sep 10, 2026, 97% of the fund by weight is stocks the S&P 500 also holds, across 31 positions, with the top ten at 55.1%. It sat 3.1% below its high of Aug 5, 2026 on Sep 11, 2026.
XBI in plain words
XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Sep 10, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 154 positions, with the top ten at 15.9%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, DIA or XBI?
- In the year to Sep 13, 2026, with distributions reinvested, DIA returned +15.6% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
- How much do DIA and XBI overlap with the S&P 500?
- By their latest filed holdings, 97% of DIA and 8% of XBI by weight is stocks the S&P 500 already holds. Between the two funds, 1% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, DIA against XBI, data as of Sep 13, 2026. https://etfiq.com/compare/any/dia-vs-xbi Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources